MIT researchers are now turning the prolific Boltz series of models into a software company that promotes open science for AI-guided therapeutics.
Organs often have fluid-filled spaces called lumens, which are crucial for organ function and serve as transport and delivery ...
Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, ...
LOWERING DRUG PRICES FOR AMERICAN PATIENTS: Today, President Donald J. Trump announced nine new agreements with major pharmaceutical companies to lower prescription drug prices for Americans in line ...
Today's article presents why Amneal should get my prior buy rating from September reaffirmed. Although some technical signals support a hold rather than bullishness, fundamental analysis shows several ...
Please provide your email address to receive an email when new articles are posted on . AIM-MASH AI Assist is the first AI drug development tool to be qualified by the FDA. The tool is designed to ...
The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their clinical trials. The agency gave a green light to the AI-Based Histologic ...
A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...
A new chemical method that could speed up the creation of medicines, materials and products people rely on every day has been developed by University of Hawaiʻi at Mānoa Department of Chemistry ...
President Donald Trump and his Pentagon chief say U.S. military strikes on suspected drug boats in waters off Latin America are saving lives by preventing narcotics from reaching America’s shores. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results